Interestingly, VEGF expression significantly correlates with LVI in lung cancer [23] and oral tegafur-uracil treatment significantly increased the survival rate of pathologic stage I NSCLC patients with VEGF overexpressing tumors [28]. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.